Abstract
The entry of subcutaneous extracellular matrix proteins into the circulation is a key step in hemostasis initiation after vascular injury. However, in cases of severe trauma, extracellular matrix proteins are unable to cover the wound, making it difficult to effectively initiate hemostasis and resulting in a series of bleeding events. Acellular-treated extracellular matrix (ECM) hydrogels are widely used in regenerative medicine and can effectively promote tissue repair due to their high mimic nature and excellent biocompatibility. ECM hydrogels contain high concentrations of extracellular matrix proteins, including collagen, fibronectin, and laminin, which can simulate subcutaneous extracellular matrix components and participate in the hemostatic process. Therefore, it has unique advantages as a hemostatic material. This paper first reviewed the preparation, composition and structure of extracellular hydrogels, as well as their mechanical properties and safety, and then analyzed the hemostatic mechanism of the hydrogels to provide a reference for the application and research, and development of ECM hydrogels in the field of hemostasis.
1 Introduction
Uncontrolled bleeding is a major challenge in trauma care and surgery. Rapid and effective hemostasis is essential to improve care quality and save lives (Yang et al., 2019; Fan et al., 2021). Conventional hemostatic materials, such as tourniquets, gauze, and bandages, have shown limited efficacy in controlling bleeding (Chen et al., 2020). Moreover, gauze or bandages need to be completely removed (Leonhardt et al., 2019) after hemostasis because they are non-biodegradable, resulting in secondary injury, delayed healing, and additional pain. Therefore, there has been widespread interest in developing novel hemostatic materials and techniques. The ideal hemostatic material should have the following characteristics (Ellis-Behnke, 2011; Zhong et al., 2021): 1) the ability to quickly form thrombus; 2) It should be biocompatible, biodegradable, and conducive to accelerating wound healing; 3) stable, cost-effective, and safe.
As a novel polymer material, a hydrogel is a three-dimensional network structure with high water content (Zhang et al., 2021). The hydrogel can be applied to various irregular wounds and intraluminal injuries (Deng et al., 2017; Palomino-Durand et al., 2019) due to its injectability and fluidity, which is crucial for rapid and effective hemostasis. Furthermore, the excellent biodegradability and biocompatibility ensure the safety of hydrogel-based biomaterials for in vivo application and enhance their ability to promote wound healing (Labay et al., 2019). Therefore, hydrogel-based hemostatic materials have unique advantages.
Hemostasis refers to the quick stopping of bleeding (Zhang et al., 2020; D'Andrea et al., 2009; Wang et al., 2021; Zheng et al., 2020). Bleeding caused by small vessel injuries usually stops automatically within a few minutes. This phenomenon is called physiologic hemostasis. Physiologic hemostasis is one of the important protective mechanisms of the body, which include three steps: first, the injured small blood vessel immediately constricts to seal the vessel and reduce bleeding. Second, the subcutaneous matrix promotes platelet aggregation and adhesion, forming a soft hemostatic plug to fill the wound. Third, by activating the blood coagulation system, soluble fibrinogen in the plasma is converted into insoluble fibrin polymer, forming a firm mixture composed of fibrin and platelets, effectively stopping bleeding (Wang et al., 2021). However, physiological hemostasis only works in case of minor trauma (Zheng et al., 2020). Injury to an artery or viscera makes it difficult for the contracted vessels to cover the wound surface, preventing the subendothelial matrix from playing its role effectively. The subcutaneous extracellular matrix is essential for hemostasis because it contains numerous extracellular matrix proteins and can promote hemostasis in different ways (Watson, 2009; Bergmeier and Hynes, 2012; Wang et al., 2016a). Therefore, it is a novel idea to use an exogenous extracellular matrix to promote wound hemostasis when bleeding caused by trauma exceeds the ability of self-hemostasis.
ECM hydrogel has attracted much attention in the field of tissue repair and regenerative medicine in recent years due to its good cytocompatibility, biodegradability, and ability to induce tissue regeneration (Zhang et al., 2021). Native hydrogels contain a host of ECM proteins that can mimic the subcutaneous matrix to promote hemostasis. Regeneration and hemostasis can cooperate to provide tissue specific therapies. For example, When liver, kidney, or spleen tissue is injured and bleeding due to surgery or trauma, as shown in Figure 1, the corresponding ECM hydrogel of the liver, kidney, or spleen can be injected to halt bleeding and promote tissue regeneration. This review further introduces the preparation, composition, structure of ECM hydrogels, as well as their mechanical property and safety, and analyzes the role of various extracellular matrix components in hemostasis. It can provide a reference for future hemostatic material research.
FIGURE 1
2 Overview of extracellular matrix hydrogels
2.1 Source of extracellular matrix materials
The extracellular matrix can originate from cell-derived matrix, various tissues, and organs of mammals. ECM derived from in vitro cultured cell constructs provides a promising alternative for creating tissue engineered scaffolds (Cheng et al., 2014). For example, osteogenic ECMs can be constructed in vitro by culturing specific cells such as mesenchymal stem cells (Zeitouni et al., 2012), chondrocytes (Lau et al., 2012) or osteoblasts (Tour et al., 2011) under osteogenic medium. The extracellular matrix of animal origin is primarily xenogeneic, commonly derived from pig tissues and organs, but also from human cadavers and rarely from autogenic sources (Zhang et al., 2021). The sources of autologous and allogeneic tissue are minimal. Various tissues from different animals, such as the bladder (Kao et al., 2020) and heart (Seif-Naraghi et al., 2013) of pigs and the shin bone of cattle (Sawkins et al., 2013), have been widely used to overcome the shortage of human tissue to create decellularized ECM (dECM). Human-derived ECM can be sourced from cadavers, diseased or injured tissues and organs of patients, and donated tissues from human tissue banks. Obtaining autologous tissue-derived extracellular matrix requires surgical intervention (Fuller et al., 2013), decellularization, and detoxification procedures, which makes the process time-consuming.
2.2 Preparation of extracellular matrix hydrogels
Decellularization of biomaterials removes cellular components while maintaining the original structure, composition, biochemical, and mechanical properties of natural ECMs. Researchers have developed various decellularization methods, including physical, chemical, and enzyme treatments and combinations of these methods. For example, Sellaro et al. utilized mechanical agitation, trypsin/Ethylene diamine tetraacetic acid (EDTA), sodium deoxycholic (SDC), and Triton X-100 to create porcine liver ECM (Sellaro et al., 2010). However, each of the techniques mentioned above has its benefits and limitations. The physical method causes minimal damage to the tissue structure, but it is difficult to remove cellular components effectively (Burk et al., 2014). Chemical agents can effectively eliminate cellular components while destroying extracellular matrix proteins (Kasimir et al., 2003). Protein composition and content significantly affect the formation of extracellular matrix hydrogels. Therefore, it is crucial to consider the effect of chemical reagents on extracellular matrix proteins during the decellularization process, as shown in Table 1.
TABLE 1
| Chemical reagent | Function | Effects on ECM proteins | Reference | |
|---|---|---|---|---|
| Ionic detergents | SDS | Damaging cell membranes and dissociating DNA from proteins | Damaged collagen structure, reduce GAG content and growth factors | Courtman et al. (1994) |
| SDC | Kasimir et al. (2003) | |||
| Non-ionic Detergents | Trition X 100 | Destroyed collagen structure, increased collagen degeneration and reduce laminins/fibronectin content | Cartmell and Dunn (2000) | |
| Huh et al. (2018) | ||||
| Acids | Hydrochloric acid | Donating hydrogen ion or form a covalent bond with an electron pair to catalyze hydrolytic degradation | Reduce collagen content | Gupta et al. (2018) |
| Peracetic acid | Tsuchiya et al. (2014) | |||
| Lin et al. (2019) | ||||
| Alkalies | Ammonium hydroxide | Inducing cellular lysis by denaturation of the chromosomal DNA | Reduce GAG and collage content, eliminate ECM growth factors | Paulo Zambon, et al. (2020) |
| Sodium hydroxide | Sheridan et al. (2012) | |||
| Calcium hydroxide | Mendoza-Novelo et al. (2011) | |||
| Sodium sulfide | Brown et al. (2011) | |||
| Simões et al. (2017) | ||||
| Sengyoku et al. (2018) | ||||
| Chelators | EDTA | Bind divalent metal cations at cell-adhesion sites of the ECM causing cell and ECM dissociation | Disrupt protein-protein interactions, and denature proteins in ECM | Brown et al. (2011) |
| EGTA | Loneker et al. (2016) | |||
| Enzymes | Nuclease | Cleave nucleic acids | Harmful effects on the ECM constituents such as GAG, laminin and collagen IV | Ali et al. (2019) |
| Dispase | Cleave collagen Ⅳ and fibronectin | Pati et al. (2014) | ||
| Lipase | Catalyze the hydrolysis of lipids and aids in delipidation | Rahman et al. (2018) | ||
| Phospholipase | Hydrolyze phospholipid components of cells and solubilizes cells | Yang et al. (2018) | ||
| Trypsin | Cleave arginine and lysine | Meder et al. (2021) | ||
| Kuljanin et al. (2017) | ||||
| Chirco et al. (2017) | ||||
The function and effection of acellular agents on ECM proteins in the process of decellularization.
Abbreviations: SDS, sodium dodecyl sulfate; SDC, Sodium deoxycholate; EDTA, ethylene diamine tetraacetic acid; EGTA, ethylene glycol tetraacetic acid.
The formation of extracellular matrix-derived hydrogels after decellularization is based on the self-assembly of collagen and is influenced by glycosaminoglycans, proteoglycans, and various proteins (Saldin et al., 2017; Zhang et al., 2021). The powdered decellularized extracellular matrix (dECM) is first dissolved into a homogeneous solution by enzymatic hydrolysis and acid dissolution. The formation of cross-linking gel can then be induced by adjusting the temperature, pH, or addition of cross-linking agent (Uriel et al., 2008). After the ECM powder is digested into a solution with pepsin, it contains dispersed collagen, glycosaminoglycan, proteoglycan, and ECM protein monomer. Under the suitable temperature and pH conditions or the addition of cross-linking agent, intramolecular and intermolecular cross-links of the three-dimensional helical structure of collagen monomers can be generated by covalent bonding to improve the tension and stability of collagen fibers and making ECM gel solution. Small intestinal submucosa (Mao et al., 2022), bladder (Kobayashi et al., 2020), fat (Tan et al., 2017), heart (Seif-Naraghi et al., 2013), cornea (Yazdanpanah et al., 2021a), dermis (Wolf et al., 2012), central nervous system (Tukmachev et al., 2016), umbilical cord (Výborný et al., 2019) and pancreas (Sackett et al., 2018) have been used to prepare ECM hydrogels successfully.
2.3 Constitutive structure of ECM hydrogels
Extracellular matrix-derived hydrogels are naturally occurring substances. After acellular treatment, the extracellular matrix retains the intrinsic structural and chemical integrity of the original tissue, which consists mainly of protein and non-protein components such as collagen, elastin, fibronectin, laminin, glycosaminoglycan, and hyaluronic acid (Halper, 2021). The ECM of each tissue is produced by its resident cells through interactions with other cell types. These cells secrete molecules that develop unique tissue structures and biochemical properties, creating an ideal microenvironment for their function. Therefore, the ECM formed by different tissues and organs after acellular treatment differs in composition, structure, and content as show in Table 2. Collagen is the main component of ECM hydrogel. Davidov et al. (2021) performed a quantitative analysis of hydrogels’ composition; artery-derived hydrogels contained approximately 64% collagen, while heart muscle, pancreas, and fat-derived hydrogels contained 20% more collagen than artery-derived hydrogels, ranging from 84% to 91%. Fibronectin (FN) is a multidomain glycoprotein present in most extracellular matrices and is involved in cell adhesion, migration, metastasis, proliferation, and differentiation (Xiao et al., 2018). Laminin is a high molecular weight multifunctional protein found in the extracellular matrix. Laminin-mediated interactions are crucial for cellular architecture formation through cell adhesion, spreading, and migration (Higaki et al., 2002). The ECM is also composed of many glycosaminoglycans (GAGs) mixtures that bind growth factors and improve water retention while giving the ECM some gel-like properties. The amount of GAG left in the tissue after decellularization largely depends on the method of decellularization. For example, ion stain removers are often used during decellularization to remove GAG from the ECM (Ebrahimi Sadrabadi et al., 2021). Therefore, ECM-derived hydrogels have a very complex composition in which different components play different roles in hemostasis.
TABLE 2
ECM hydrogels derived from pig and human.
2.4 The safety of ECM hydrogels
ECM hydrogels are widely used as scaffold materials in regenerative medicine due to their unique biological activity and good biocompatibility (Saldin et al., 2017; Zhang et al., 2021). ECM components are less vulnerable to rejection because their structure and function are highly conserved and nearly identical across species. ECM hydrogels, which eliminate many cell components compared to allograft and xenograft, can effectively reduce the potential for adverse host reactions after implantation. When compared to other synthetic polymers, ECM components of hydrogels are retained after decellularization, providing a better microenvironment for cell attachment and cell-ECM interaction (Badylak and Gilbert, 2008; Saldin et al., 2017).
ECM scaffolds are manufactured using various tissues derived from cells, animals, or humans. The dECM scaffold derived from cells has several advantages. For example, cultured cells can be screened for pathogens and then kept free of pathogens for ECM. In addition, after acellular treatment, the cell-derived matrix has improved plasticity and optimal porosity due to its loose structure (Zhu et al., 2021). Importantly, they can generate autologous ECM scaffolds from autologous cells, thereby avoiding the adverse host reactions induced by allogeneic or heterogeneous materials and circumventing the limited availability of autologous tissue. However, cell-derived dECM typically has limited mechanical properties (Guan et al., 2022).
Pigs are the primary source of animal extracellular matrix components. Compared with other animals, porcine organs are readily available in larger quantities and are comparable in size and function to human organs. Therefore, pigs have always been the preferred source of cellular scaffolds of tissues and organs (Zhang et al., 2021). Many commercialized porcine extracellular matrix products (Prima™ Plus, Hancock® II, Mosaic®, Freestyle®, Permacol®, Strattice™, MatriStem®, Oasis®, and CuffPatch®) (Table 2) are employed in tissue regeneration. For example, Oasis®, derived from acellular porcine small intestinal submucosa, is an acellular product primarily used in the treatment of chronic wounds (Holmes et al., 2013). Extracellular matrix hydrogels are prepared based on extracellular matrix scaffolds. Traverse et al. (2019) conducted a first-in-man, single-arm, multicenter trial to demonstrate the safety, feasibility, and preliminary efficacy of percutaneous trans-endocardial delivery of VentriGel (an extracellular matrix hydrogel derived from decellularized porcine myocardium) in early and late MI (Myocardial infarction) patients with left ventricular (LV) dysfunction, which is the first demonstration of using a decellularized ECM hydrogel in any tissue in patients. Interestingly, ECM hydrogel can be used as an embolic agent to embolize arteries and promote vascular healing. Animal experiments have shown no signs of lymphadenopathy, pulmonary emboli, or stroke, suggesting that ECM-based nanocomposite hydrogel was safe even when used in blood vessels (Hu et al., 2020). Porcine endogenous retroviruses (PERV) are present in the pig genome and could pose a safety hazard (Kimsa et al., 2014). However, the risk is minimal because the source pigs will be housed in specific pathogen-free, biosecure conditions and are regularly monitored (Cooper et al., 2018).
Various human tissues and organs, such as cardiac tissue (Johnson et al., 2014), pancreas (Sackett et al., 2018), and adipose (Chen et al., 2021), are utilized to produce dECM. Gao et al. developed a human cardiac tissue-derived scaffold using decellularization, which improved the functional behavior of cardiac progenitor cells from patients with congenital heart disease, including cell adhesion, survival, and proliferation (Gao et al., 2022). Human-derived ECM materials are not controllable and are easily affected by donor age, degree of damage, and storage period (Johnson et al., 2014). However, those materials can effectively prevent the transmission of xenogenetic diseases.
3 Hemostatic mechanism of hydrogel
3.1 Physical barrier
Temperature-sensitive hydrogels are of interest for achieving effective hemostasis and wound closure because they are suitable for wounds of various shapes (Liu et al., 2018; Cao et al., 2020). ECM hydrogels have good temperature sensitivity, existing in a liquid state at 4°C and a gel state at 37°C. Fully gelated ECMs usually appear as irregular nanofiber scaffolds with interconnected pores on SEM images (Freytes et al., 2008; Wolf et al., 2012). The thermal characteristics of hydrogels can be used to stop bleeding in wounds, especially irregular wounds. The liquid hydrogel can cover irregular wounds at low temperatures; when the temperature rises to body temperature, the hydrogel transforms into a gel. The microstate showed irregular fibrous reticular scaffolds that mechanically sealed the vascular breach and formed a physical barrier as shown in Figure 2. The hydrogel is injectable and can be injected into deep tissue wounds for hemostasis (Pourshahrestani et al., 2020). Compared to natural tissues, hydrogels exhibit poor mechanical properties (Grover et al., 2014; Ahearne and Coyle, 2016), making them susceptible to deformation. Increasing hydrogel mechanical strength can effectively facilitate wound sealing and prevent blood loss. There are two main methods to improve the mechanical properties of ECM hydrogel. The first approach is to increase the initial concentration of the extracellular matrix. The second approach is to use cross-linking techniques to improve the mechanical properties of hydrogels.
FIGURE 2
3.1.1 Effect of concentration on mechanical properties
Extracellular matrix hydrogels have different mechanical properties closely connected to their composition. Davidov et al. compared the mechanical properties of ECM hydrogels derived from the porcine liver, pancreas, artery, and heart (Davidov et al., 2021). It was found that arterial hydrogels exhibit the highest mechanical properties, while pancreatic hydrogels exhibit the lowest. The mechanical properties of hydrogels vary with the species of origin. The porcine myocardial matrix is significantly higher than the Human myocardial matrix by measuring storage and loss modulus with a parallel plate rheometer (Johnson et al., 2014). The mechanical properties of hydrogels vary with the species of origin Matrix, and mechanical properties can be effectively enhanced by increasing the concentration of its extracellular matrix. Tissue fibrosis typically increases various extracellular matrix components. Normal heart tissue has an elastic modulus of 10–15 kPa, while fibrotic tissue can be 2 to 10 times stiffer. Healthy lung tissue is relatively soft, ranging from 1 to 5 kPa, and can stiffen above 10 kPa in pulmonary fibrosis (Hewawasam et al., 2023).
Hydrogels prepared with a high concentration of extracellular matrix typically have greater mechanical strength. Medberry et al. (2013) prepared brain-ECM, spinal cord-ECM, and urinary bladder-ECM hydrogels. As the temperature rapidly increased from 10°C to 37°C, the maximum storage modulus, maximum loss modulus, and the time to complete gelation increased for the three hydrogels with increasing ECM concentration. Dermal-ECM hydrogels were evaluated for their structural, mechanical, and in vitro cell response characteristics, which were found to depend on the ECM concentration (Wolf et al., 2012). These findings suggest that the ECM concentration can influence and control the physical properties of an ECM hydrogel.
3.1.2 Effect of crosslinking technology on mechanical properties
The application of crosslinking agents has been investigated to enhance the mechanical properties of hydrogels (Pilipchuk et al., 2013; Ahearne and Coyle, 2016; Parthiban et al., 2021). Crosslinking agents are introduced to modify various biomaterials and improve their mechanical properties by considering their composition and structural characteristics. Cell compatibility is a crucial evaluation factor, for example, using glutaraldehyde (GA) as a crosslinking agent might cause cell toxicity (Wang et al., 2014). Therefore, it is vital to consider the reaction of crosslinking agents on cells while enhancing mechanical features, as shown in Table 3.
TABLE 3
| Tissue source | Crosslinking mode | Function | Cytocompatibility | Reference |
|---|---|---|---|---|
| Human derived dentin matrix | dECM strongly interacted with the GelMA matrix via covalent interactions between aldehyde in dECM and amine groups in GelMA | The compressive strength improved 2-fold with increasing dECM content from 2.5 wt% to 10 wt% | Hydrogels showed a tendency to increase cell viability with the increase of dECM concentration | Sadeghian et al. (2023) |
| Human derived bone matrix | Demineralized and decellularized bone matrix was functionalized with methacrylate group to form photocrosslinked methacrylate bone ECM hydrogel | The mechanical properties of BoneMA were tunable, with the elastic modulus increasing as a function of photocrosslinking time | Hydrogels supported vascularization of endothelial cells and within a day led to the formation of interconnected vascular networks | Parthiban et al. (2021) |
| Rat derived dermal matrix | The dermal extracellular matrix hydrogel was prepared and covalently cross-linked by glutaraldehyde (GA) | Compression tests indicated that elastic moduli and yield stress values increased signifificantly with GA exposure time | Hydrogels supported cell adhesion and showed good tolerance in vivo | Pilipchuk et al. (2013) |
| porcine cornea matrix | The cornea, liver and heart extracellular matrix hydrogel was prepared respectively and covalently cross-linked by UVA-riboflavin | It can be used to enhance the mechanical properties of ECM Hydrogels. The stiffness can be controlled by varying the UVA exposure time | Hydrogels did not have any significant adverse effects on cell viability | Ahearne and Coyle (2016) |
| ovine liver matrix | ||||
| ovine heart matrix | ||||
| Porcine myocardial matrix | Cross-linking the ECM proteins with an amine-reactive PEG-star | Addition of PEG to the myocardial matrix did increase the stiffness of the hydrogels, although this was greater with the radical polymerization with the four-armed PEG | Hydrogels did not prevent cell adhesion and migration through the hydrogels | Wang et al. (2014) |
| Myocardial matrix, PEG-acrylate, and Irgacure 2,959 were mixedand Gel formation photo-induced radical polymerization | ||||
| Myocardial matrix, PEG-diacrylate, and Irgacure 2,959 were mixed and Gel formation photo-induced radical polymerization | ||||
| Crosslinking of the myocardial matrix was induced during self-assembly, through the addition of glutaraldehyde (GA) | Crosslinking increases the stiffness and elasticity of the hydrogel, as assessed by parallel plate rheology | Migration of cells through crosslinked gels was slowed, but not inhibited | Singelyn and Christman (2011) | |
| human cartilage matrix | The forming hydrogels were composed of different ionic crosslinked alginate concentrations with 1% w/v enzymatically crosslinked phenolized cartilage ECM, resulting in an interpenetrating polymer network (IPN) | The results demonstrated that upon increasing the alginate concentration, the compression modulus improved | Hydrogels provide a suitable microenvironment for the growth and viability of Human primary chondrocyte cells | Shojarazavi et al. (2021) |
Application of crosslinking agents in ECM hydrogels.
Abbreviations: BG, bioactive glass; GelMA, gelatin methacrylate; BoneMA, a photocrosslinkable methacrylate bone ECM, hydrogel-bone-derived biomaterial; PEG-star, Four-arm polyethylene glycol. UVA, Ultraviolet Radiation A.
3.2 Simulate physiologic hemostasis
The inner wall of most blood vessels is covered by a continuous layer of endothelial cells that seals the subcutaneous extracellular matrix components and provides an anti-thrombotic surface for the body. Moreover, it actively secretes platelet activation inhibitors, such as nitric oxide and prostacyclin (Hein et al., 2009). Which regulate blood circulation and prevent thrombosis (Gimbrone et al., 2000). However, in the case of trauma, the ruptured vascular wall is difficult to effectively play the role of hemostasis, leading to a series of bleeding and even death events. Exogenous ECM hydrogels mimic the significant components of the extracellular matrix, including collagen, laminin, fibronectin, and vitronectin, which induce platelet adhesion and activation and promote hemostasis and thrombosis. Due to the different molecular environments of the original tissue ECM, these hydrogels have varying compositions and contents, which play different roles in hemostasis (Figure 3). According to the research of Cai et al., 2021 as shown in Figure 4, extracellular matrix hydrogels derived from porcine dermal were used in liver, kidney, and vascular trauma models of Sprague-Dawley rats and the pathological section suggests thrombosis, which was found that ECM hydrogels effectively played a hemostatic role.
FIGURE 3
FIGURE 4
3.2.1 The role of collagen in hemastasis
Collagen is the main component of extracellular matrix hydrogel and is also a potent platelets activator. Its hemostatic mechanism is the effect on platelets to shorten the thrombosis time. Glycoprotein VI (GPVI) and α2β1 integrin are the collagen receptors on platelets (Sarratt et al., 2005). Collagen interacts directly with platelets via GPVI, mediates platelet activation, and integrin α2β1, which supports platelet adhesion to collagen (Jarvis et al., 2008; Attwood et al., 2013). Furthermore, collagen induces exposure of procoagulant phospholipids on platelets via GPVI(Manon-Jensen et al., 2016). The exposure of phospholipids provides an assembly site for coagulation factors, resulting in thrombin production required for platelet-fibrin thrombus. Simultaneously, collagen activates the intrinsic coagulation pathway by binding to factor XII(FXII, a coagulation factor) (van der Meijden et al., 2009). Therefore, collagen can promote blood coagulation through various pathways and plays a leading role in the process of ECM hemostasis.
3.2.2 The role of laminin in hemastasis
Laminin is a heterotrimeric glycoprotein found in almost all ECM tissues, especially in the basement membrane of the vasculature. Platelet recruitment by VWF (von Willebrand Factor) enables integrin α6β1 and GPVI to interact with laminin, supporting integrin activation and resulting in stable adhesion and platelet aggregates formation (Inoue et al., 2006). This mechanism of platelet adhesion and activation is similar to platelet-collagen interaction; integrin α2β1 binding to collagen facilitates the interaction between GPVI and collagen. Further studies by Inoue et al. (2008) discovered that immobilized laminin promotes platelet recruitment under shear flow in a GPIbα-vWF dependent manner. White-Adams et al. demonstrated that laminin can activate FXII and that surface-associated laminin alone can trigger fibrin- and platelet-rich clots formation under shear (White-Adams et al., 2010). Therefore, the process of platelet recruitment, activation, and adhesion on laminin is mechanically similar to the interaction between platelets and collagen under shearing, and both can activate FXII, suggesting that laminin and collagen may jointly promote hemostasis.
Laminin is a weak platelet agonist, with a 10-fold lower affinity for the interaction between laminin and GPVI than collagen binding (Watson, 2009). Because superficial injury does not expose fibrous collagen, laminin-mediated platelet adhesion activation may be more effective. When the vessel wall is severely damaged, the exposed collagen in the deeper layers of the extracellular matrix collaborates with the superficial laminin to promote hemostasis. Moreover, laminin-111 can induce fibronectin assembly after adhesion to platelets via integrin α6β1. Therefore, laminin can indirectly affect hemostasis and thrombosis by regulating fibronectin deposition in thrombus (Cho and Mosher, 2006). As an important component of extracellular matrix hydrogel, laminin can collaborate with other hydrogel components to exert a hemostatic effect.
3.2.3 The role of fibronectin in hemastasis
Fibronectin (FN) is a dimeric protein composed of two approximately 250 kDa subunits that have many biological functions and is involved in cell migration, adhesion, proliferation, hemostasis, and tissue repair (Wang et al., 2008; Tong et al., 2016). FN is present as plasma Fibronectin (pFN) and cell Fibronectin (cFN) in extracellular connective tissue matrix and extracellular fluid (Roberts et al., 2020). pFN is produced by hepatocytes and endothelial cells in the liver and exists as a soluble non-complex molecule in the blood, whereas cFN is secreted and synthesized by fibroblast and mesenchymal cells and exists in the ECM as an insoluble polymer. Fibronectin is an essential component of tissue ECM, and it exists in two forms: as a soluble form in plasma and as an insoluble polymerized form. The main difference between the two forms of existence is that cFN has an extra domain A (EDA) and an extra domain B (EDB) compared to pFN(Wang et al., 2008).
The fibrillar cFN in the ECM is a strong prothrombotic surface that promotes platelet adhesion, aggregation, and coagulation. Fibrillar cFN effectively supports platelet adhesion, and adherent platelets can be activated to form a thrombus. This process depends on the integration of α5β1 and αIIbβ3, together with the GPIb-V-IX complexes, GPVI, and TLR4 (Maurer et al., 2015). Integrins α5β1 and αIIbβ3 ensure the initial phase of platelet adhesion to fibrillar cFN. Integrins can effectively promote platelet activation once platelets are attached to fibrillar cFn (McCarty et al., 2004; Lickert et al., 2022). GPIb-V-IX complex is a membrane protein component on the surface of platelets that plays a key role in platelet thrombosis initiation and coagulation. The binding of von Willebrand factor (VWF) to the platelet membrane glycoprotein (GP) Ib-IX-V complex initiates a signaling cascade that activates αIIbβ3 and causes platelet aggregation (Liu et al., 2005). As a fibronectin receptor, activated αIIbβ3 can further promote platelet adhesion and activation. Maurer et al. (2015) decreased thrombus formation on fibrillar cFN by antagonizing the binding of VWF and GPIb-V-IX complexes. GPVI is not only a collagen and laminin agonist but also a ligand and agonist for fibronectin, which, together with integrins, promotes platelet adhesion activation (Perrella et al., 2021). TLR4 is an EDA-binding receptor involved in platelet aggregation on fibrillar cFN, and the volume of thrombus on fibrillar cFN was reduced by using TLR4 blockers (Maurer et al., 2015; Prakash et al., 2015). Fibronectin can bind to various platelet receptors and play an important role in hemostasis and thrombosis.
3.2.4 The role of vitronectin in hemastasis
Vitronectin (VN) is a multifunctional 75-kDa glycoprotein present in plasma, extracellular matrix, and the α-granules of platelets (Bergmeier and Hynes, 2012). Vitronectin can not only improve platelet adhesion and aggregation during thrombus formation, but it also promotes thrombus stability. Ekmekci et al. (2002) discovered high vitronectin levels in growing thrombus, suggesting that it is actively involved in thrombosis after vascular injury. Vitronectin has two fibrin binding sites that have the potential to link fibrin monomers to polymers, binding them to fibrin clots to promote further platelet adhesion and aggregation (Schvartz et al., 2002). Platelets are covered by VN after initial binding to fibrin, and VN incorporated into fibrin clots enhances platelet adhesion and aggregation via the homotypic binding of VN molecules present on platelet surfaces and in clots. Wu et al. (2004) perfused whole blood onto a fibrin network made from purified fibrinogen, resulting in approximately 20% of the surface being covered with platelets binding purified polymeric VN to the fibrin network, resulting in a 2-fold increase in platelet surface coverage and enhanced platelet aggregate formation.
Plasminogen activator inhibitor-1 (PAI-1) can prevent fibrinolysis by inhibiting the conversion of plasminogen to plasmin. VN can bind to the β-sheet-A subunit of PAI-1, stabilize its structure, inhibit its spontaneous inactivation, and prolong its role in the fibrinolytic system, reducing the fibrinolysis of thrombi (Eitzman et al., 1995; Hess et al., 1995). Multiple protein components of ECM hydrogel could effectively induce platelet adhesion and aggregation to achieve hemostasis; vitronectin further promotes thrombogenesis in platelets by binding to fibrin sites. Moreover, thrombus stability was effectively enhanced by stabilizing the PAI-I structure and inhibiting thrombus degradation.
4 Conclusion and future perspectives
This study discusses the manufacturing methods, composition, safety, mechanical properties, and role of extracellular matrix proteins in the hemostasis of extracellular matrix hydrogels. With continued research and development, ECM hydrogel will be the most competitive material in the field of hemostasis. ECM hydrogels have developed a mature preparation and validation system to promote tissue regeneration, including material acquisition, acellular treatment, hydrogel formation, in vitro cytocompatibility experiment, in vivo regeneration experiment, and clinical trials. These experimental and theoretical findings facilitate the investigation of ECM hydrogels for hemostasis. Although ECM hydrogel has the potential to be hemostatic, significant experimental studies are required before clinical application. The formation and hemostatic function of the hydrogel primarily depend on extracellular matrix proteins. Protein contents vary between hydrogels from different sources and tissues, and the application of acellular reagents may destroy extracellular matrix proteins. Therefore, the hemostatic effects of hydrogels from various sources and tissues can be compared to select appropriate hemostatic agents. Optimizing the decellularization method and reducing the destructive effect of chemical reagents on ECM are essential processes. Combining tissue regeneration and hemostasis will be the focus of future research on ECM hydrogel. The primary focus of research is to promote tissue healing while enhancing the hemostatic effect. Although the hemostatic effect can be improved by introducing cross-linking agent or increasing extracellular matrix protein, hydrogel’s regeneration and repair effect is easily influenced. In conclusion, extracellular matrix hydrogels have shown immense potential in the field of hemostasis. However, further research and exploration are necessary fully realize its potential.
Statements
Author contributions
DC contributed to conception and design of the study. WW organized the database. All authors contributed to the article and approved the submitted version.
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by Zhejiang Province Public Welfare Technology Application Research Project (CN), China (Grant No. LGF20H060009).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
Adam YoungD.BajajV.ChristmanK. L. (2014). Award winner for outstanding research in the PhD category, 2014 Society for Biomaterials annual meeting and exposition, Denver, Colorado, April 16-19, 2014: Decellularized adipose matrix hydrogels stimulate in vivo neovascularization and adipose formation. J. Biomed. Mater. Res. Part A.102 (6), 1641–1651. 10.1002/jbm.a.35109
2
AhearneM.CoyleA. (2016). Application of UVA-riboflavin crosslinking to enhance the mechanical properties of extracellular matrix derived hydrogels. J. Mech. Behav. Biomed. Mater.54, 259–267. 10.1016/j.jmbbm.2015.09.035
3
AliM.PrA. K.YooJ. J.ZahranF.AtalaA.LeeS. J. (2019). A photo-crosslinkable kidney ECM-derived bioink accelerates renal tissue formation. Adv. Healthc. Mater.8 (7), e1800992. 10.1002/adhm.201800992
4
AttwoodS. J.SimpsonA. M.HamaiaS. W.BihanD.RoyD.FarndaleR. W.et al (2013). Measurement of the interaction between recombinant I-domain from integrin alpha 2 beta 1 and a triple helical collagen peptide with the GFOGER binding motif using molecular force spectroscopy. Int. J. Mol. Sci.14 (2), 2832–2845. 10.3390/ijms14022832
5
BadylakS. F.GilbertT. W. (2008). Immune response to biologic scaffold materials. Seminars Immunol.20 (2), 109–116. 10.1016/j.smim.2007.11.003
6
BarberF. A.HerbertM. A.CoonsD. A. (2006). Tendon augmentation grafts: Biomechanical failure loads and failure patterns. Arthrosc. J. Arthrosc. Relat. Surg. official Publ. Arthrosc. Assoc. N. Am. Int. Arthrosc. Assoc.22 (5), 534–538. 10.1016/j.arthro.2005.12.021
7
BergmeierW.HynesR. O. (2012). Extracellular matrix proteins in hemostasis and thrombosis. Cold Spring Harb. Perspect. Biol.4 (2), a005132. 10.1101/cshperspect.a005132
8
BrownB. N.FreundJ. M.HanL.RubinJ. P.ReingJ. E.JeffriesE. M.et al (2011). Comparison of three methods for the derivation of a biologic scaffold composed of adipose tissue extracellular matrix. Tissue Eng. Part C. Methods17 (4), 411–421. 10.1089/ten.TEC.2010.0342
9
BrunnerM.SchneiderI.GüntherK.GrützmannR.MatzelK. E. (2019). Permacol™ collagen paste for cryptoglandular and Crohn's anal fistula. Tech. coloproctology23 (2), 135–141. 10.1007/s10151-019-01932-z
10
BurkJ.ErbeI.BernerD.KaczaJ.KasperC.PfeifferB.et al (2014). Freeze-thaw cycles enhance decellularization of large tendons. Tissue Eng. Part C Methods20 (4), 276–284. 10.1089/ten.TEC.2012.0760
11
CaiD.ChenS.WuB.ChenJ.TaoD.LiZ.et al (2021). Construction of multifunctional porcine acellular dermal matrix hydrogel blended with vancomycin for hemorrhage control, antibacterial action, and tissue repair in infected trauma wounds. Mater. today. Bio.12, 100127. 10.1016/j.mtbio.2021.100127
12
CaoJ.SuM.HasanN.LeeJ.KwakD.KimD. Y.et al (2020). Nitric oxide-releasing thermoresponsive pluronic F127/alginate hydrogel for enhanced antibacterial activity and accelerated healing of infected wounds. Pharmaceutics12 (10), 926. 10.3390/pharmaceutics12100926
13
CartmellJ. S.DunnM. G. (2000). Effect of chemical treatments on tendon cellularity and mechanical properties. J. Biomed. Mater. Res.49 (1), 134–140. 10.1002/(sici)1097-4636(200001)49:1<134::aid-jbm17>3.0.co;2-d
14
ChaimovD.BaruchL.KrishtulS.Meivar-LevyI.FerberS.MachlufM. (2017). Innovative encapsulation platform based on pancreatic extracellular matrix achieve substantial insulin delivery. J. Control. release official J. Control. Release Soc.257, 91–101. 10.1016/j.jconrel.2016.07.045
15
ChenF. M.LiuX. (2016). Advancing biomaterials of human origin for tissue engineering. Prog. Polym. Sci.53, 86–168. 10.1016/j.progpolymsci.2015.02.004
16
ChenK. Y.ChenY. C.LinT. H.YangC. Y.KuoY. W.LeiU. (2020). Hemostatic enhancement via chitosan is independent of classical clotting pathways-A quantitative study. Polymers12 (10), 2391. 10.3390/polym12102391
17
ChenZ.ZhangB.ShuJ.WangH.HanY.ZengQ.et al (2021). Human decellularized adipose matrix derived hydrogel assists mesenchymal stem cells delivery and accelerates chronic wound healing. J. Biomed. Mater. Res. Part A109 (8), 1418–1428. 10.1002/jbm.a.37133
18
ChengC. W.SolorioL. D.AlsbergE. (2014). Decellularized tissue and cell-derived extracellular matrices as scaffolds for orthopaedic tissue engineering. Biotechnol. Adv.32 (2), 462–484. 10.1016/j.biotechadv.2013.12.012
19
ChengM. H.UrielS.MoyaM. L.Francis-SedlakM.WangR.HuangJ. J.et al (2010). Dermis-derived hydrogels support adipogenesis in vivo. J. Biomed. Mater. Res. Part A.92 (3), 852–858. 10.1002/jbm.a.32410
20
ChircoK. R.WorthingtonK. S.Flamme-WieseM. J.RikerM. J.AndradeJ. D.UeberheideB. M.et al (2017). Preparation and evaluation of human choroid extracellular matrix scaffolds for the study of cell replacement strategies. Acta biomater.57, 293–303. 10.1016/j.actbio.2017.05.011
21
ChoJ.MosherD. F. (2006). Characterization of fibronectin assembly by platelets adherent to adsorbed laminin-111. J. thrombosis haemostasis JTH4 (5), 943–951. 10.1111/j.1538-7836.2006.01862.x
22
ChristT.GrubitzschH.ClausB.KonertzW. (2014). Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age. J. Thorac. Cardiovasc. Surg.147 (1), 264–269. 10.1016/j.jtcvs.2012.10.032
23
CooperD. K. C.GastonR.EckhoffD.LadowskiJ.YamamotoT.WangL.et al (2018). Xenotransplantation-the current status and prospects. Br. Med. Bull.125 (1), 5–14. 10.1093/bmb/ldx043
24
CourtmanD. W.PereiraC. A.KashefV.McCombD.LeeJ. M.WilsonG. J. (1994). Development of a pericardial acellular matrix biomaterial: Biochemical and mechanical effects of cell extraction. J. Biomed. Mater. Res.28 (6), 655–666. 10.1002/jbm.820280602
25
CrapoP. M.WangY. (2010). Small intestinal submucosa gel as a potential scaffolding material for cardiac tissue engineering. Acta biomater.6 (6), 2091–2096. 10.1016/j.actbio.2009.10.048
26
D'AndreaG.ChettaM.MargaglioneM. (2009). Inherited platelet disorders: Thrombocytopenias and thrombocytopathies. Blood Transfus. = Trasfus. del sangue7 (4), 278–292. 10.2450/2009.0078-08
27
DavidovT.EfraimY.HayamR.OieniJ.BaruchL.MachlufM. (2021). Extracellular matrix hydrogels originated from different organs mediate tissue-specific properties and function. Int. J. Mol. Sci.22 (21), 11624. 10.3390/ijms222111624
28
DemantM.LauritzenE.LangC. L.BredgaardR.GramkowC. (2022). A case of disintegrated Strattice™ 4 years after immediate breast reconstruction. Ann. R. Coll. Surg. Engl.104 (3), e57–e59. 10.1308/rcsann.2021.0107
29
DengY.RenJ.ChenG.LiG.WuX.WangG.et al (2017). Injectable in situ cross-linking chitosan-hyaluronic acid based hydrogels for abdominal tissue regeneration. Sci. Rep.7 (1), 2699. 10.1038/s41598-017-02962-z
30
DeQuachJ. A.MezzanoV.MiglaniA.LangeS.KellerG. M.SheikhF.et al (2010). Simple and high yielding method for preparing tissue specific extracellular matrix coatings for cell culture. PloS one5 (9), e13039. 10.1371/journal.pone.0013039
31
Ebrahimi SadrabadiA.BaeiP.HosseiniS.Baghaban EslaminejadM. (2021). Decellularized extracellular matrix as a potent natural biomaterial for regenerative medicine. Adv. Exp. Med. Biol.1341, 27–43. 10.1007/5584_2020_504
32
EitzmanD. T.FayW. P.LawrenceD. A.Francis-ChmuraA. M.ShoreJ. D.OlsonS. T.et al (1995). Peptide-mediated inactivation of recombinant and platelet plasminogen activator inhibitor-1 in vitro. J. Clin. investigation95 (5), 2416–2420. 10.1172/JCI117937
33
EkmekciH.SonmezH.EkmekciO. B.OzturkZ.DomanicN.KokogluE. (2002). Plasma vitronectin levels in patients with coronary atherosclerosis are increased and correlate with extent of disease. J. thrombosis thrombolysis14 (3), 221–225. 10.1023/a:1025000810466
34
Ellis-BehnkeR. (2011). At the nanoscale: Nanohemostat, a new class of hemostatic agent. Wiley Interdiscip. Rev. Nanomedicine nanobiotechnology.3 (1), 70–78. 10.1002/wnan.110
35
FanX.LiM.YangQ.WanG.LiY.LiN.et al (2021). Morphology-controllable cellulose/chitosan sponge for deep wound hemostasis with surfactant and pore-foaming agent. Mater. Sci. Eng. C, Mater. Biol. Appl.118, 111408. 10.1016/j.msec.2020.111408
36
Fernández-PérezJ.AhearneM. (2019). The impact of decellularization methods on extracellular matrix derived hydrogels. Sci. Rep.9 (1), 14933. 10.1038/s41598-019-49575-2
37
FreytesD. O.MartinJ.VelankarS. S.LeeA. S.BadylakS. F. (2008). Preparation and rheological characterization of a gel form of the porcine urinary bladder matrix. Biomaterials29 (11), 1630–1637. 10.1016/j.biomaterials.2007.12.014
38
FuW.XuP.FengB.LuY.BaiJ.ZhangJ.et al (2019). A hydrogel derived from acellular blood vessel extracellular matrix to promote angiogenesis. J. biomaterials Appl.33 (10), 1301–1313. 10.1177/0885328219831055
39
FuY.FanX.TianC.LuoJ.ZhangY.DengL.et al (2016). Decellularization of porcine skeletal muscle extracellular matrix for the formulation of a matrix hydrogel: A preliminary study. J. Cell. Mol. Med.20 (4), 740–749. 10.1111/jcmm.12776
40
FullerM. K.FaulkD. M.SundaramN.MaheM. M.StoutK. M.von FurstenbergR. J.et al (2013). Intestinal stem cells remain viable after prolonged tissue storage. Cell. tissue Res.354 (2), 441–450. 10.1007/s00441-013-1674-y
41
GaetaniR.AudeS.DeMaddalenaL. L.StrassleH.DzieciatkowskaM.WorthamM.et al (2018). Evaluation of different decellularization protocols on the generation of pancreas-derived hydrogels. Tissue Eng. Part C. Methods24 (12), 697–708. 10.1089/ten.TEC.2018.0180
42
GaoL.LiX.TanR.CuiJ.SchmullS. (2022). Human-derived decellularized extracellular matrix scaffold incorporating autologous bone marrow stem cells from patients with congenital heart disease for cardiac tissue engineering. Bio-medical Mater. Eng.33 (5), 407–421. 10.3233/BME-211368
43
GetovaV. E.van DongenJ. A.BrouwerL. A.HarmsenM. C. (2019). Adipose tissue-derived ECM hydrogels and their use as 3D culture scaffold. Artif. cells, nanomedicine, Biotechnol.47 (1), 1693–1701. 10.1080/21691401.2019.1608215
44
GhumanH.MauneyC.DonnellyJ.MassensiniA. R.BadylakS. F.ModoM. (2018). Biodegradation of ECM hydrogel promotes endogenous brain tissue restoration in a rat model of stroke. Acta biomater.80, 66–84. 10.1016/j.actbio.2018.09.020
45
GimbroneM. A.JrTopperJ. N.NagelT.AndersonK. R.Garcia-CardeñaG. (2000). Endothelial dysfunction, hemodynamic forces, and atherogenesisa. Ann. N. Y. Acad. Sci.902, 230–240. 10.1111/j.1749-6632.2000.tb06318.x
46
GroverG. N.RaoN.ChristmanK. L. (2014). Myocardial matrix-polyethylene glycol hybrid hydrogels for tissue engineering. Nanotechnology25 (1), 014011. 10.1088/0957-4484/25/1/014011
47
GuanY.YangB.XuW.LiD.WangS.RenZ.et al (2022). Cell-derived extracellular matrix materials for tissue engineering. Tissue Eng. Part B, Rev.28 (5), 1007–1021. 10.1089/ten.TEB.2021.0147
48
GuptaS. K.MishraN. C.DhasmanaA. (2018). Decellularization methods for scaffold fabrication. Methods Mol. Biol. Clift. N.J.).1577, 1–10. 10.1007/7651_2017_34
49
HalperJ. (2021). Basic components of connective tissues and extracellular matrix: Fibronectin, fibrinogen, laminin, elastin, fibrillins, fibulins, matrilins, tenascins and thrombospondins. Adv. Exp. Med. Biol.1348, 105–126. 10.1007/978-3-030-80614-9_4
50
HeinT. W.QamiraniE.RenY.KuoL. (2009). C-Reactive protein impairs coronary arteriolar dilation to prostacyclin synthase activation: Role of peroxynitrite. J. Mol. Cell. Cardiol.47 (2), 196–202. 10.1016/j.yjmcc.2009.04.015
51
HessS.KanseS. M.KostC.PreissnerK. T. (1995). The versatility of adhesion receptor ligands in haemostasis: Morpho-regulatory functions of vitronectin. Thrombosis haemostasis74 (1), 258–265. 10.1055/s-0038-1642687
52
HewawasamR. S.BlombergR.ŠerbedžijaP.MaginC. M. (2023). Chemical modification of human decellularized extracellular matrix for incorporation into phototunable hybrid-hydrogel models of tissue fibrosis. ACS Appl. Mater. interfaces15 (12), 15071–15083. 10.1021/acsami.2c18330
53
HigakiY.SchulleryD.KawataY.ShnyrevaM.AbrassC.BomsztykK. (2002). Synergistic activation of the rat laminin gamma1 chain promoter by the gut-enriched Kruppel-like factor (GKLF/KLF4) and Sp1. Nucleic acids Res.30 (11), 2270–2279. 10.1093/nar/30.11.2270
54
HolmesC.WrobelJ. S.MaceachernM. P.BolesB. R. (2013). Collagen-based wound dressings for the treatment of diabetes-related foot ulcers: A systematic review. Diabetes, metabolic syndrome Obes. targets Ther.6, 17–29. 10.2147/DMSO.S36024
55
HuJ.AltunI.ZhangZ.AlbadawiH.SalomaoM. A.MayerJ. L.et al (2020). Bioactive-tissue-derived nanocomposite hydrogel for permanent arterial embolization and enhanced vascular healing. Adv. Mater. Deerf. Beach, Fla.)32 (33), e2002611. 10.1002/adma.202002611
56
HuhM. I.LeeK. P.KimJ.YiS.ParkB. U.KimH. K. (2018). Generation of femtosecond laser-cut decellularized corneal lenticule using hypotonic trypsin-EDTA solution for corneal tissue engineering.J. Ophthalmol.2018, 1–12. 10.1155/2018/2590536
57
InoueO.Suzuki-InoueK.McCartyO. J.MoroiM.RuggeriZ. M.KunickiT. J.et al (2006). Laminin stimulates spreading of platelets through integrin α6β1–dependent activation of GPVI. Blood107 (4), 1405–1412. 10.1182/blood-2005-06-2406
58
InoueO.Suzuki-InoueK.OzakiY. (2008). Redundant mechanism of platelet adhesion to laminin and collagen under flow: Involvement of von Willebrand factor and glycoprotein ib-IX-V. J. Biol. Chem.283 (24), 16279–16282. 10.1074/jbc.C700241200
59
JamiesonW. R.RiessF. C.RaudkiviP. J.MetrasJ.BusseE. F.GoldsteinJ.et al (2011). Medtronic mosaic porcine bioprosthesis: Assessment of 12-year performance. J. Thorac. Cardiovasc. Surg.142 (2), 302–307.e2. 10.1016/j.jtcvs.2010.08.090
60
JarvisG. E.RaynalN.LangfordJ. P.OnleyD. J.AndrewsA.SmethurstP. A.et al (2008). Identification of a major GpVI-binding locus in human type III collagen. Blood111 (10), 4986–4996. 10.1182/blood-2007-08-108472
61
JeffordsM. E.WuJ.ShahM.HongY.ZhangG. (2015). Tailoring material properties of cardiac matrix hydrogels to induce endothelial differentiation of human mesenchymal stem cells. ACS Appl. Mater. interfaces7 (20), 11053–11061. 10.1021/acsami.5b03195
62
JohnsonT. D.DequachJ. A.GaetaniR.UngerleiderJ.ElhagD.NigamV.et al (2014). Human versus porcine tissue sourcing for an injectable myocardial matrix hydrogel. Biomaterials Sci.2, 735–744. 10.1039/C3BM60283D
63
JohnsonT. D.HillR. C.DzieciatkowskaM.NigamV.BehfarA.ChristmanK. L.et al (2016). Quantification of decellularized human myocardial matrix: A comparison of six patients. Clin. Appl.10 (1), 75–83. 10.1002/prca.201500048
64
KaoC. Y.NguyenH. Q.WengY. C. (2020). Characterization of porcine urinary bladder matrix hydrogels from sodium dodecyl sulfate decellularization method. Polymers12 (12), 3007. 10.3390/polym12123007
65
KasimirM. T.RiederE.SeebacherG.SilberhumerG.WolnerE.WeigelG.et al (2003). Comparison of different decellularization procedures of porcine heart valves. Int. J. Artif. organs26 (5), 421–427. 10.1177/039139880302600508
66
KellawayS. C.RobertonV.JonesJ. N.LoczenskiR.PhillipsJ. B.WhiteL. J. (2023). Engineered neural tissue made using hydrogels derived from decellularised tissues for the regeneration of peripheral nerves. Acta biomater.157, 124–136. 10.1016/j.actbio.2022.12.003
67
KhazaalJ.RagagniM.ParkerJ.TimekT.MurphyE.HeiserJ.et al (2022). Freestyle aortic bioprostheses in patients 60 Years old and younger. Seminars Thorac. Cardiovasc. Surg.34 (3), 870–877. 10.1053/j.semtcvs.2021.08.003
68
KimK.KimM. S. (2016). An injectable hydrogel derived from small intestine submucosa as a stem cell carrier. J. Biomed. Mater. Res. Part B, Appl. biomaterials104 (8), 1544–1550. 10.1002/jbm.b.33504
69
KimS.MinS.ChoiY. S.JoS. H.JungJ. H.HanK.et al (2022). Tissue extracellular matrix hydrogels as alternatives to Matrigel for culturing gastrointestinal organoids. Nat. Commun.13 (1), 1692. 10.1038/s41467-022-29279-4
70
KimsaM. C.Strzalka-MrozikB.KimsaM. W.GolaJ.NicholsonP.LopataK.et al (2014). Porcine endogenous retroviruses in xenotransplantation--molecular aspects. Viruses6 (5), 2062–2083. 10.3390/v6052062
71
KobayashiM.KadotaJ.HashimotoY.FujisatoT.NakamuraN.KimuraT.et al (2020). Elastic modulus of ECM hydrogels derived from decellularized tissue affects capillary network formation in endothelial cells. Int. J. Mol. Sci.21 (17), 6304. 10.3390/ijms21176304
72
KuljaninM.BrownC. F. C.RaleighM. J.LajoieG. A.FlynnL. E. (2017). Collagenase treatment enhances proteomic coverage of low-abundance proteins in decellularized matrix bioscaffolds. Biomaterials144, 130–143. 10.1016/j.biomaterials.2017.08.012
73
LabayC.HamoudaI.TampieriF.GinebraM. P.CanalC. (2019). Production of reactive species in alginate hydrogels for cold atmospheric plasma-based therapies. Sci. Rep.9 (1), 16160. 10.1038/s41598-019-52673-w
74
LauT. T.LeeL. Q.VoB. N.SuK.WangD. A. (2012). Inducing ossification in an engineered 3D scaffold-free living cartilage template. Biomaterials33 (33), 8406–8417. 10.1016/j.biomaterials.2012.08.025
75
LeonhardtE. E.KangN.HamadM. A.WooleyK. L.ElsabahyM. (2019). Absorbable hemostatic hydrogels comprising composites of sacrificial templates and honeycomb-like nanofibrous mats of chitosan. Nat. Commun.10 (1), 2307. 10.1038/s41467-019-10290-1
76
LiangR.KnightK.EasleyD.PalcseyS.AbramowitchS.MoalliP. A. (2017). Towards rebuilding vaginal support utilizing an extracellular matrix bioscaffold. Acta biomater.57, 324–333. 10.1016/j.actbio.2017.05.015
77
LickertS.KennyM.SelcukK.MehlJ. L.BenderM.FrühS. M.et al (2022). Platelets drive fibronectin fibrillogenesis using integrin αIIbβ3. Sci. Adv.8 (10), eabj8331. 10.1126/sciadv.abj8331
78
LinC. Y.LiuT. Y.ChenM. H.SunJ. S.ChenM. H. (2016). An injectable extracellular matrix for the reconstruction of epidural fat and the prevention of epidural fibrosis. Biomed. Mater. (Bristol, Engl.11 (3), 035010. 10.1088/1748-6041/11/3/035010
79
LinH. J.WangT. J.LiT. W.ChangY. Y.SheuM. T.HuangY. Y.et al (2019). Development of decellularized cornea by organic acid treatment for corneal regeneration. Tissue Eng. Part A25 (7-8), 652–662. 10.1089/ten.TEA.2018.0162
80
LiuJ.PestinaT. I.BerndtM. C.JacksonC. W.GartnerT. K. (2005). Botrocetin/VWF-induced signaling through GPIb-IX-V produces TxA2 in an αIIbβ3-and aggregation-independent manner. Blood106 (8), 2750–2756. 10.1182/blood-2005-04-1667
81
LiuX.GanH.HuC.SunW.ZhuX.MengZ.et al (2018). Silver sulfadiazine nanosuspension-loaded thermosensitive hydrogel as a topical antibacterial agent. Int. J. nanomedicine14, 289–300. 10.2147/IJN.S187918
82
LonekerA. E.FaulkD. M.HusseyG. S.D'AmoreA.BadylakS. F. (2016). Solubilized liver extracellular matrix maintains primary rat hepatocyte phenotype in-vitro. J. Biomed. Mater. Res. Part A.104 (4), 957–965. 10.1002/jbm.a.35636
83
López-MartínezS.CampoH.de Miguel-GómezL.FausA.NavarroA. T.DíazA.et al (2021a). A natural xenogeneic endometrial extracellular matrix hydrogel toward improving current human in vitro models and future in vivo applications. Front. Bioeng. Biotechnol.9, 639688. 10.3389/fbioe.2021.639688
84
López-MartínezS.Rodríguez-EgurenA.de Miguel-GómezL.Francés-HerreroE.FausA.DíazA.et al (2021b). Bioengineered endometrial hydrogels with growth factors promote tissue regeneration and restore fertility in murine models. Acta biomater.135, 113–125. 10.1016/j.actbio.2021.08.025
85
Manon-JensenT.KjeldN. G.KarsdalM. A. (2016). Collagen-mediated hemostasis. J. thrombosis haemostasis JTH.14 (3), 438–448. 10.1111/jth.13249
86
MaoX.YaoL.LiM.ZhangX.WengB.ZhuW.et al (2022). Enhancement of tendon repair using tendon-derived stem cells in small intestinal submucosa via M2 macrophage polarization. Cells11 (17), 2770. 10.3390/cells11172770
87
MaurerE.SchaffM.ReceveurN.BourdonC.MercierL.NieswandtB.et al (2015). Fibrillar cellular fibronectin supports efficient platelet aggregation and procoagulant activity. Thrombosis haemostasis114 (6), 1175–1188. 10.1160/TH14-11-0958
88
McCartyO. J.ZhaoY.AndrewN.MacheskyL. M.StauntonD.FramptonJ.et al (2004). Evaluation of the role of platelet integrins in fibronectin-dependent spreading and adhesion. J. thrombosis haemostasis JTH.2 (10), 1823–1833. 10.1111/j.1538-7836.2004.00925.x
89
MedberryC. J.CrapoP. M.SiuB. F.CarruthersC. A.WolfM. T.NagarkarS. P.et al (2013). Hydrogels derived from central nervous system extracellular matrix. Biomaterials34 (4), 1033–1040. 10.1016/j.biomaterials.2012.10.062
90
MederT.PrestT.SkillenC.MarchalL.YupanquiV. T.SolettiL.et al (2021). Nerve-specific extracellular matrix hydrogel promotes functional regeneration following nerve gap injury. NPJ Regen. Med.6 (1), 69. 10.1038/s41536-021-00174-8
91
Mendoza-NoveloB.AvilaE. E.Cauich-RodríguezJ. V.Jorge-HerreroE.RojoF. J.GuineaG. V.et al (2011). Decellularization of pericardial tissue and its impact on tensile viscoelasticity and glycosaminoglycan content. Acta biomater.7 (3), 1241–1248. 10.1016/j.actbio.2010.11.017
92
OkadaM.PayneT. R.OshimaH.MomoiN.TobitaK.HuardJ. (2010). Differential efficacy of gels derived from small intestinal submucosa as an injectable biomaterial for myocardial infarct repair. Biomaterials31 (30), 7678–7683. 10.1016/j.biomaterials.2010.06.056
93
OzpinarE. W.FreyA. L.ArthurG. K.Mora-NavarroC.BiehlA.SniderD. B.et al (2021). Dermal extracellular matrix-derived hydrogels as an in vitro substrate to study mast cell maturation. Tissue Eng. Part A27 (15-16), 1008–1022. 10.1089/ten.TEA.2020.0142
94
Palomino-DurandC.LopezM.CazauxF.MartelB.BlanchemainN.ChaiF. (2019). Influence of the Soluble⁻Insoluble ratios of cyclodextrins polymers on the viscoelastic properties of injectable Chitosan⁻Based hydrogels for biomedical application. Polymers11 (2), 214. 10.3390/polym11020214
95
ParthibanS. P.AthirasalaA.TahayeriA.AbdelmoniemR.GeorgeA.BertassoniL. E. (2021). BoneMA-synthesis and characterization of a methacrylated bone-derived hydrogel for bioprinting ofin-vitrovascularized tissue constructs. Biofabrication13 (3), 035031. 10.1088/1758-5090/abb11f
96
PatiF.JangJ.HaD. H.Won KimS.RhieJ. W.ShimJ. H.et al (2014). Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink. Nat. Commun.5, 3935. 10.1038/ncomms4935
97
Paulo ZambonJ.AtalaA.YooJ. J. (2020). Methods to generate tissue-derived constructs for regenerative medicine applications. Methods (San Diego, Calif.)171, 3–10. 10.1016/j.ymeth.2019.09.016
98
PelosoA.UrbaniL.CravediP.KatariR.MaghsoudlouP.FallasM. E.et al (2016). The human pancreas as a source of protolerogenic extracellular matrix scaffold for a new-generation bioartificial endocrine pancreas. Ann. Surg.264 (1), 169–179. 10.1097/SLA.0000000000001364
99
PerrellaG.NagyM.WatsonS. P.HeemskerkJ. W. M. (2021). Platelet GPVI (glycoprotein VI) and thrombotic complications in the venous system. Arteriosclerosis, thrombosis, Vasc. Biol.41 (11), 2681–2692. 10.1161/ATVBAHA.121.316108
100
PilipchukS. P.VaicikM. K.LarsonJ. C.GazyakanE.ChengM. H.BreyE. M. (2013). Influence of crosslinking on the stiffness and degradation of dermis-derived hydrogels. J. Biomed. Mater. Res. Part A.101 (10), 2883–2895. 10.1002/jbm.a.34602
101
PoonC. J.Pereira E CottaM. V.SinhaS.PalmerJ. A.WoodsA. A.MorrisonW. A.et al (2013). Preparation of an adipogenic hydrogel from subcutaneous adipose tissue. Acta biomater.9 (3), 5609–5620. 10.1016/j.actbio.2012.11.003
102
PourshahrestaniS.ZeimaranE.KadriN. A.MutluN.BoccacciniA. R. (2020). Polymeric hydrogel systems as emerging biomaterial platforms to enable hemostasis and wound healing. Adv. Healthc. Mater.9 (20), 2000905. 10.1002/adhm.202000905
103
PrakashP.KulkarniP. P.LentzS. R.ChauhanA. K. (2015). Cellular fibronectin containing extra domain A promotes arterial thrombosis in mice through platelet Toll-like receptor 4. Blood125 (20), 3164–3172. 10.1182/blood-2014-10-608653
104
RahmanS.GriffinM.NaikA.SzarkoM.ButlerP. E. M. (2018). Optimising the decellularization of human elastic cartilage with trypsin for future use in ear reconstruction. Sci. Rep.8 (1), 3097. 10.1038/s41598-018-20592-x
105
RamzanF.EkramS.FrazierT.SalimA.MohiuddinO. A.KhanI. (2022). Decellularized human umbilical tissue-derived hydrogels promote proliferation and chondrogenic differentiation of mesenchymal stem cells. Bioeng. (Basel, Switz.9 (6), 239. 10.3390/bioengineering9060239
106
RobertsA. L.MavlyutovT. A.PerlmutterT. E.CurryS. M.HarrisS. L.ChauhanA. K.et al (2020). Fibronectin extra domain A (FN-EDA) elevates intraocular pressure through Toll-like receptor 4 signaling. Sci. Rep.10 (1), 9815. 10.1038/s41598-020-66756-6
107
SackettS. D.TremmelD. M.MaF.FeeneyA. K.MaguireR. M.BrownM. E.et al (2018). Extracellular matrix scaffold and hydrogel derived from decellularized and delipidized human pancreas. Sci. Rep.8 (1), 10452. 10.1038/s41598-018-28857-1
108
SadeghianA.KharazihaM.KhoroushiM. (2023). Dentin extracellular matrix loaded bioactive glass/GelMA support rapid bone mineralization for potential pulp regeneration. Int. J. Biol. Macromol.234, 123771. 10.1016/j.ijbiomac.2023.123771
109
SaldinL. T.CramerM. C.VelankarS. S.WhiteL. J.BadylakS. F. (2017). Extracellular matrix hydrogels from decellularized tissues: Structure and function. Acta biomater.49, 1–15. 10.1016/j.actbio.2016.11.068
110
SarrattK. L.ChenH.ZutterM. M.SantoroS. A.HammerD. A.KahnM. L. (2005). GPVI and α2β1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow. Blood106 (4), 1268–1277. 10.1182/blood-2004-11-4434
111
SawkinsM. J.BowenW.DhaddaP.MarkidesH.SidneyL. E.TaylorA. J.et al (2013). Hydrogels derived from demineralized and decellularized bone extracellular matrix. Acta biomater.9 (8), 7865–7873. 10.1016/j.actbio.2013.04.029
112
SchvartzI.SegerD.Maik-RachlineG.KreizmanT.ShaltielS. (2002). Truncated vitronectins: Binding to immobilized fibrin and to fibrin clots, and their subsequent interaction with cells. Biochem. biophysical Res. Commun.290 (2), 682–689. 10.1006/bbrc.2001.6273
113
Seif-NaraghiS. B.SingelynJ. M.SalvatoreM. A.OsbornK. G.WangJ. J.SampatU.et al (2013). Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction. Sci. Transl. Med.5 (173), 173ra25. 10.1126/scitranslmed.3005503
114
SellaroT. L.RanadeA.FaulkD. M.McCabeG. P.DorkoK.BadylakS. F.et al (2010). Maintenance of human hepatocyte function in vitro by liver-derived extracellular matrix gels. Tissue Eng. Part a.16 (3), 1075–1082. 10.1089/ten.TEA.2008.0587
115
SengyokuH.TsuchiyaT.ObataT.DoiR.HashimotoY.IshiiM.et al (2018). Sodium hydroxide based non-detergent decellularizing solution for rat lung. Organogenesis14 (2), 94–106. 10.1080/15476278.2018.1462432
116
SeoY.JeongS.ChungJ. J.KimS. H.ChoiN.JungY. (2020). Development of an anisotropically organized brain dECM hydrogel-based 3D neuronal culture platform for recapitulating the brain microenvironment in vivo. ACS biomaterials Sci. Eng.6 (1), 610–620. 10.1021/acsbiomaterials.9b01512
117
SheridanW. S.DuffyG. P.MurphyB. P. (2012). Mechanical characterization of a customized decellularized scaffold for vascular tissue engineering. J. Mech. Behav. Biomed. Mater.8, 58–70. 10.1016/j.jmbbm.2011.12.003
118
ShojarazaviN.MashayekhanS.PazookiH.MohsenifardS.BaniasadiH. (2021). Alginate/cartilage extracellular matrix-based injectable interpenetrating polymer network hydrogel for cartilage tissue engineering. J. biomaterials Appl.36 (5), 803–817. 10.1177/08853282211024020
119
SimõesI. N.ValeP.SokerS.AtalaA.KellerD.NoivaR.et al (2017). Acellular urethra bioscaffold: Decellularization of whole urethras for tissue engineering applications. Sci. Rep.7, 41934. 10.1038/srep41934
120
SimsaR.RothenbücherT.GürbüzH.GhoshehN.EmneusJ.JenndahlL.et al (2021). Brain organoid formation on decellularized porcine brain ECM hydrogels. PloS one16 (1), 0245685. 10.1371/journal.pone.0245685
121
SingelynJ. M.ChristmanK. L. (2011). Modulation of material properties of a decellularized myocardial matrix scaffold. Macromol. Biosci.11 (6), 731–738. 10.1002/mabi.201000423
122
TanQ. W.ZhangY.LuoJ. C.ZhangD.XiongB. J.YangJ. Q.et al (2017). Hydrogel derived from decellularized porcine adipose tissue as a promising biomaterial for soft tissue augmentation. J. Biomed. Mater. Res. Part A.105 (6), 1756–1764. 10.1002/jbm.a.36025
123
TongY. F.LiuY.HuZ. X.LiZ. C. (2016). Protocatechuic aldehyde inhibits TNF-α-induced fibronectin expression in human umbilical vein endothelial cells via a c-Jun N-terminal kinase dependent pathway. Exp. Ther. Med.11 (1), 277–282. 10.3892/etm.2015.2896
124
TourG.WendelM.TcacencuI. (2011). Cell-derived matrix enhances osteogenic properties of hydroxyapatite. Tissue Eng. Part A17 (1-2), 127–137. 10.1089/ten.TEA.2010.0175
125
TraverseJ. H.HenryT. D.DibN.PatelA. N.PepineC.SchaerG. L.et al (2019). First-in-Man study of a cardiac extracellular matrix hydrogel in early and late myocardial infarction patients. JACC. Basic Transl. Sci.4 (6), 659–669. 10.1016/j.jacbts.2019.07.012
126
TremmelD. M.SackettS. D.FeeneyA. K.MitchellS. A.SchaidM. D.PolyakE.et al (2022). A human pancreatic ECM hydrogel optimized for 3-D modeling of the islet microenvironment. Sci. Rep.12 (1), 7188. 10.1038/s41598-022-11085-z
127
TsuchiyaT.BalestriniJ. L.MendezJ.CalleE. A.ZhaoL.NiklasonL. E. (2014). Influence of pH on extracellular matrix preservation during lung decellularization. Tissue Eng. Part C. Methods.20 (12), 1028–1036. 10.1089/ten.TEC.2013.0492
128
TukmachevD.ForostyakS.KociZ.ZaviskovaK.VackovaI.VybornyK.et al (2016). Injectable extracellular matrix hydrogels as scaffolds for spinal cord injury repair. Tissue Eng. Part A22 (3-4), 306–317. 10.1089/ten.TEA.2015.0422
129
UngerleiderJ. L.JohnsonT. D.RaoN.ChristmanK. L. (2015). Fabrication and characterization of injectable hydrogels derived from decellularized skeletal and cardiac muscle. Methods (San Diego, Calif.)84, 53–59. 10.1016/j.ymeth.2015.03.024
130
UrielS.HuangJ. J.MoyaM. L.FrancisM. E.WangR.ChangS. Y.et al (2008). The role of adipose protein derived hydrogels in adipogenesis. Biomaterials29 (27), 3712–3719. 10.1016/j.biomaterials.2008.05.028
131
ValfrèC.RizzoliG.ZussaC.IusP.PoleselE.MironeS.et al (2006). Clinical results of Hancock II versus Hancock standard at long-term follow-up. J. Thorac. Cardiovasc. Surg.132 (3), 595–601.e2. 10.1016/j.jtcvs.2006.03.062
132
van der MeijdenP. E.MunnixI. C.AugerJ. M.Govers-RiemslagJ. W.CosemansJ. M.KuijpersM. J.et al (2009). Dual role of collagen in factor XII-dependent thrombus formation. Blood114 (4), 881–890. 10.1182/blood-2008-07-171066
133
van DongenJ. A.GetovaV.BrouwerL. A.LiguoriG. R.SharmaP. K.StevensH. P.et al (2019). Adipose tissue-derived extracellular matrix hydrogels as a release platform for secreted paracrine factors. J. tissue Eng. Regen. Med.13 (6), 973–985. 10.1002/term.2843
134
VenturaR. D.PadalhinA. R.KimB.ParkM.LeeB. T. (2020). Evaluation of bone regeneration potential of injectable extracellular matrix (ECM) from porcine dermis loaded with biphasic calcium phosphate (BCP) powder. Mater. Sci. Eng. C, Mater. Biol. Appl.110, 110663. 10.1016/j.msec.2020.110663
135
VýbornýK.VallováJ.KočíZ.KekulováK.JirákováK.JendelováP.et al (2019). Genipin and EDC crosslinking of extracellular matrix hydrogel derived from human umbilical cord for neural tissue repair. Sci. Rep.9 (1), 10674. 10.1038/s41598-019-47059-x
136
WangF.ShiW.LiH.WangH.SunD.ZhaoL.et al (2020). Decellularized porcine cornea-derived hydrogels for the regeneration of epithelium and stroma in focal corneal defects. ocular Surf.18 (4), 748–760. 10.1016/j.jtos.2020.07.020
137
WangQ.ChenJ.WangD.ShenM.OuH.ZhaoJ.et al (2021). Rapid hemostatic biomaterial from a natural bath sponge skeleton. Mar. drugs19 (4), 220. 10.3390/md19040220
138
WangS. Y.SangJ. W.DingW.QinT. W.BaiL.ZhangJ.et al (2019). The cytoptrotection of small intestinal submucosa-derived gel in HL-1 cells during hypoxia/reoxygenation-induced injury. J. tissue Eng. Regen. Med.13 (8), 1346–1361. 10.1002/term.2878
139
WangW.ZhangX.ChaoN. N.QinT. W.DingW.ZhangY.et al (2016a). Preparation and characterization of pro-angiogenic gel derived from small intestinal submucosa. Acta biomater.29, 135–148. 10.1016/j.actbio.2015.10.013
140
WangX. Q.ChenL.PanR.ZhaoJ.LiuY.HeR. Q. (2008). An earthworm protease cleaving serum fibronectin and decreasing HBeAg in HepG2.2.15 cells. BMC Biochem.9, 30. 10.1186/1471-2091-9-30
141
WangY.GallantR. C.NiH. (2016b). Extracellular matrix proteins in the regulation of thrombus formation. Curr. Opin. Hematol.23 (3), 280–287. 10.1097/MOH.0000000000000237
142
WangZ.ZhangY.ZhangJ.HuangL.LiuJ.LiY.et al (2014). Exploring natural silk protein sericin for regenerative medicine: An injectable, photoluminescent, cell-adhesive 3D hydrogel. Sci. Rep.4, 7064. 10.1038/srep07064
143
WassenaarJ. W.GaetaniR.GarciaJ. J.BradenR. L.LuoC. G.HuangD.et al (2016). Evidence for mechanisms underlying the functional benefits of a myocardial matrix hydrogel for post-MI treatment. J. Am. Coll. Cardiol.67 (9), 1074–1086. 10.1016/j.jacc.2015.12.035
144
WatsonS. P. (2009). Platelet activation by extracellular matrix proteins in haemostasis and thrombosis. Curr. Pharm. Des.15 (12), 1358–1372. 10.2174/138161209787846702
145
White-AdamsT. C.BernyM. A.PatelI. A.TuckerE. I.GailaniD.GruberA.et al (2010). Laminin promotes coagulation and thrombus formation in a factor XII-dependent manner. J. thrombosis haemostasis JTH8 (6), 1295–1301. 10.1111/j.1538-7836.2010.03850.x
146
WolfM. T.DalyK. A.Brennan-PierceE. P.JohnsonS. A.CarruthersC. A.D'AmoreA.et al (2012). A hydrogel derived from decellularized dermal extracellular matrix. Biomaterials33 (29), 7028–7038. 10.1016/j.biomaterials.2012.06.051
147
WuJ.BrazileB.McMahanS. R.LiaoJ.HongY. (2019). Heart valve tissue-derived hydrogels: Preparation and characterization of mitral valve chordae, aortic valve, and mitral valve gels. J. Biomed. Mater. Res. Part B, Appl. biomaterials107 (5), 1732–1740. 10.1002/jbm.b.34266
148
WuY. P.BloemendalH. J.VoestE. E.LogtenbergT.de GrootP. G.GebbinkM. F.et al (2004). Fibrin-incorporated vitronectin is involved in platelet adhesion and thrombus formation through homotypic interactions with platelet-associated vitronectin. Blood104 (4), 1034–1041. 10.1182/blood-2003-12-4293
149
XiaoJ.YangW.XuB.ZhuH.ZouJ.SuC.et al (2018). Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration. BMC cancer18 (1), 976. 10.1186/s12885-018-4850-3
150
YangJ. L.YaoX.QingQ.ZhangY.JiangY. L.NingL. J.et al (2018). An engineered tendon/ligament bioscaffold derived from decellularized and demineralized cortical bone matrix. J. Biomed. Mater. Res. Part A.106 (2), 468–478. 10.1002/jbm.a.36261
151
YangX.LiuW.XiG.WangM.LiangB.ShiY.et al (2019). Fabricating antimicrobial peptide-immobilized starch sponges for hemorrhage control and antibacterial treatment. Carbohydr. Polym.222, 115012. 10.1016/j.carbpol.2019.115012
152
YazdanpanahG.JiangY.RabieeB.OmidiM.RosenblattM. I.ShokuhfarT.et al (2021b). Fabrication, rheological, and compositional characterization of thermoresponsive hydrogel from cornea. Tissue Eng. Part C. Methods27 (5), 307–321. 10.1089/ten.TEC.2021.0011
153
YazdanpanahG.ShahR.Raghurama R SomalaS.AnwarK. N.ShenX.AnS.et al (2021a). In-situ porcine corneal matrix hydrogel as ocular surface bandage. ocular Surf.21, 27–36. 10.1016/j.jtos.2021.04.004
154
ZeitouniS.KrauseU.CloughB. H.HaldermanH.FalsterA.BlalockD. T.et al (2012). Human mesenchymal stem cell-derived matrices for enhanced osteoregeneration. Sci. Transl. Med.4 (132), 132ra55. 10.1126/scitranslmed.3003396
155
ZhangD.TanQ. W.LuoJ. C.LvQ. (2018). Evaluating the angiogenic potential of a novel temperature-sensitive gel scaffold derived from porcine skeletal muscle tissue. Biomed. Mater. (Bristol, Engl.13 (5), 055003. 10.1088/1748-605X/aac275
156
ZhangH.PanD.WuX.SuW.TangX.ZhaoD.et al (2020). Platelet protease activated receptor 1 is involved in the hemostatic effect of 20(S)-Protopanaxadiol by regulating calcium signaling. Front. Pharmacol.11, 549150. 10.3389/fphar.2020.549150
157
ZhangW.DuA.LiuS.LvM.ChenS. (2021). Research progress in decellularized extracellular matrix-derived hydrogels. Regen. Ther.18, 88–96. 10.1016/j.reth.2021.04.002
158
ZhaoY.FanJ.BaiS. (2019). Biocompatibility of injectable hydrogel from decellularized human adipose tissue in vitro and in vivo. J. Biomed. Mater. Res. Part B, Appl. biomaterials107 (5), 1684–1694. 10.1002/jbm.b.34261
159
ZhengC.ZengQ.PimpiS.WuW.HanK.DongK.et al (2020). Research status and development potential of composite hemostatic materials. J. Mater. Chem. B8 (25), 5395–5410. 10.1039/d0tb00906g
160
ZhongY.HuH.MinN.WeiY.LiX.LiX. (2021). Application and outlook of topical hemostatic materials: A narrative review. Ann. Transl. Med.9 (7), 577. 10.21037/atm-20-7160
161
ZhuW.CaoL.SongC.PangZ.JiangH.GuoC. (2021). Cell-derived decellularized extracellular matrix scaffolds for articular cartilage repair. Int. J. Artif. organs44 (4), 269–281. 10.1177/0391398820953866
Summary
Keywords
extracellular matrix hydrogel, hemostasis, hemostatic mechanism, extracellular matrix components (ECM), hemorrhage
Citation
Cai D and Weng W (2023) Development potential of extracellular matrix hydrogels as hemostatic materials. Front. Bioeng. Biotechnol. 11:1187474. doi: 10.3389/fbioe.2023.1187474
Received
16 March 2023
Accepted
02 June 2023
Published
13 June 2023
Volume
11 - 2023
Edited by
Marta S. Carvalho, University of Lisbon, Portugal
Reviewed by
Vipuil Kishore, Florida Institute of Technology, United States
Diana Soares Da Costa, University of Minho, Portugal
Updates
Copyright
© 2023 Cai and Weng.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Wei Weng, cd19942022@126.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.